Docs reduce opioid prescriptions, but pain patients suffer

A new survey finds more than half of doctors are writing fewer opioid prescriptions.

When the government released strict new guidelines last March to limit prescribing of opioid painkillers, many doctors worried they would impede access to narcotic painkillers for patients who legitimately need them to treat chronic pain. A new survey suggests that is exactly what has happened.

More than half of physicians in the U.S. are writing fewer opioid prescriptions and nearly one in 10 have stopped prescribing the painkillers altogether, according to a survey conducted for The Boston Globe. However, more than one-third of the nearly 3,000 doctors who responded to the online survey said the cutback in prescribing has hurt patients with chronic pain, the newspaper reported.

The survey was conducted in December for the newspaper by SERMO, a physicians’ social network, to ask about changes in prescribing practices. Responding to the growing number of overdoses and deaths from opioids, the Centers for Disease Control and Prevention issued guidelines last year advising physicians to prescribe treatments other than opioids for chronic pain outside of active cancer treatment, palliative care and end-of-life care. Doctors had concerns that a backlash against opioid use would harm patients who need and benefit from opioid therapy.

Featured Webinar

Patient experience and the bottom-line impact on a practice

Practices that deliver exceptional experience often demonstrate strong financial performance and efficient operations. Join us to learn how to identify the most impactful connections between patient experience and financial performance, how to measure, track and improve patient experience as it relates to the bottom line, and identify patient experience measures that affect financial performance.

Of those doctors who said they reduced or eliminated opioid prescribing in the past year or two, 34% said there were “too many hassles and risks” and 29% cited an improved understanding of opioid risks. The survey also found that nearly three-quarters of doctors said chronic pain patients have adequate access to treatments other than opioids.

Suggested Articles

Several experts say most insurers aren't factoring COVID-19 into their 2021 premiums for the ACA exchanges due to massive uncertainty.

With large numbers of Americans skeptical of a COVID-19 vaccine, CVS views its pharmacists as playing a key role in assuaging fears, said its CEO.

The COVID-19 pandemic is driving enormous demand for virtual mental health care services. Here is how much utilization has increased during COVID-19.